A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Vectors and Compositions for Treating Hemoglobinopathies
Patent Title: Vectors and Compositions for Treating HemoglobinopathiesFiling Date: November 17, 2025Status: Patent application published / pendingAssignee: bluebird bio, Inc.Patent Category: Gene‑therapy vectors and therapeutic compositions What This Patent Covers Although the full patent specification…
-
Prime editing-installed suppressor tRNAs for disease-agnostic genome editing
Published in Nature (Nov 19, 2025) — a pioneering paper by Sarah E. Pierce, Steven Erwood, Keyede Oye, Meirui An, Nicholas Krasnow, Emily Zhang, Aditya Raguram, David R. Liu, and colleagues. This study introduced a…
-
Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences
What It Covers This patent protects foundational next-generation CRISPR-Cas9 ribonucleoprotein (RNP) technology that has direct importance for therapeutic genome editing: Core Invention Key Technical Elements Why It’s Important 1. Direct relevance to CRISPR therapies This…
BioTech IP Review 